The Impact of Dairy Products in the Development of Type 2 Diabetes: Where Does the Evidence Stand in 2019?

Advances in Nutrition

Volumn 10, Issue 6, 2019, Pages 1066-1075

  Guo, Jing ^a   Givens, D Ian ^a   Astrup, Arne ^b   Bakker, Stephan J L ^c   Goossens, Gijs H ^d   Kratz, Mario ^e   Marette, André ^f   Pijl, Hanno ^g   Soedamah Muthu, Sabita S ^a,h  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e USA   (United States)

^f UNIVERSITÉ LAVAL   (Canada)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h TILBURG UNIVERSITY   (Netherlands)

Author keywords

cheese; dairy; milk; type 2 diabetes; yogurt

Indexed keywords

FATTY ACID; MONOUNSATURATED FATTY ACID; PALMITOLEIC ACID; YOGHURT;

DAIRY PRODUCT; DIET; DRUG THERAPY; FAT INTAKE; FEEDING BEHAVIOR; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIET; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FEEDING BEHAVIOR; HUMANS; YOGURT;

EID: 85075014115     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.1093/advances/nmz050     Document Type: Review

References (106)

1. International Diabetes Federation. IDF diabetes atlas [Internet]. Brussels: International Diabetes Federation; 2017 [cited 2018 Feb 28]. Available from: http://diabetesatlas.org/IDF-Diabetes-Atlas-8e-interactive-EN/.
2. Nathan DM. Diabetes: Advances in diagnosis and treatment. JAMA 2015;314:1052-62.
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403.
4. Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet 2018;391:541-51.
5. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention andmanagement of type 2 diabetes: Dietary components and nutritional strategies. Lancet 2014;383:1999-2007.
6. Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumäki M, Hämälaïnen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: Results from a randomized clinical trial. J Am Soc Nephrol 2003;14:S108-13.
7. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, et al. Effects of diet and exercise in preventing NIDDMin people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
8. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-97.
9. Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH, Blaak EE. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: The SLIM study. Diabet Med 2008;25:597-605.
10. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008;94:206-18.
11. Goossens GH. The metabolic phenotype in obesity: Fat mass, body fat distribution, adipose tissue function. Obes Facts 2017;10:207-15.
12. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: A matter of oxygen Front Endocrinol (Lausanne) 2015;6:55.
13. Buemann B, Sorensen TI, Pedersen O, Black E, Holst C, Toubro S, Echwald S, Holst JJ, Rasmussen C, Astrup A. Lower-body fatmass as an independent marker of insulin sensitivity-the role of adiponectin. Int J Obes (Lond) 2005;29:624-31.
14. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: The AusDiab Study. Int J Obes Relat Metab Disord 2004;28:402-9.
15. Vasan SK, Osmond C, Canoy D, Christodoulides C, Neville MJ, Di Gravio C, Fall CHD, Karpe F. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes (Lond) 2018;42:850-7.
16. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;96:735-47.
17. Schwingshackl L, Hoffmann G, Schwedhelm C, Kalle-Uhlmann T, Missbach B, Knuppel S, Boeing H. Consumption of dairy products in relation to changes in anthropometric variables in adult populations: A systematic review and meta-analysis of cohort studies. PLoS One 2016;11:e0157461.
18. Stonehouse W, Wycherley T, Luscombe-Marsh N, Taylor P, Brinkworth G, Riley M. Dairy intake enhances body weight and composition changes during energy restriction in 18-50-year-old adults-a meta-analysis of randomized controlled trials. Nutrients 2016;8:394.
19. National Health Service (NHS). Dairy and alternatives in your diet [Internet]. UK: NHS; 2018 [cited 2019 May 9]. Available from: http://www.nhs.uk/Livewell/Goodfood/Pages/milk-dairy-foods.aspx.
20. Ritchie H, Reay DS, Higgins P. The impact of global dietary guidelines on climate change. Global Environ Change 2018;49:46-55.
21. Hirahatake KM, Slavin JL, Maki KC, Adams SH. Associations between dairy foods, diabetes, metabolic health: Potentialmechanisms and future directions. Metab Clin Exp 2014;63:618-27.
22. Mozaffarian D, Wu JHY. Flavonoids, dairy foods, cardiovascular andmetabolic health: A reviewof emerging biologic pathways.Circ Res 2018;122:369-84.
23. Givens DI. Saturated fats, dairy foods and health: A curious paradox Nutr Bull 2017;42:274-82.
24. MichaR, MozaffarianD. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, diabetes: A fresh look at the evidence. Lipids 2010;45:893-905.
25. Webster JL, Dunford EK, Neal BC. A systematic survey of the sodium contents of processed foods. Am J Clin Nutr 2010;91:413-20.
26. Micha R, Mozaffarian D. Trans fatty acids: Effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009;5: 335-44.
27. Liu S, van der Schouw YT, Soedamah-Muthu SS, Spijkerman AMW, Sluijs I. Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort: Associations by types, sources of fatty acids and substitution by macronutrients. Eur J Nutr 2019;58:1125-36.
28. Thorning TK, BertramHC, Bonjour JP, deGroot L, Dupont D, Feeney E, Ipsen R, Lecerf JM, Mackie A, McKinley MC, et al. Whole dairy matrix or single nutrients in assessment of health effects: Current evidence and knowledge gaps. Am J Clin Nutr 2017;105:1033-45.
29. Feeney EL, Barron R, Dible V, Hamilton Z, Power Y, Tanner L, Flynn C, Bouchier P, Beresford T, Noronha N, et al. Dairy matrix effects: Response to consumption of dairy fat differs when eaten within the cheese matrix-a randomized controlled trial. Am J Clin Nutr 2018;108:667-74.
30. McGuire S. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2011;2:293-4.
31. PublicHealth England. EatwellGuide [Internet]. 2016; London: Public Health England [cited 2018Mar 21]. Available from: http://www.gov. uk/government/publications/the-eatwell-guide.
32. Gijsbers L, Ding EL, Malik VS, de Goede J, Geleijnse JM, Soedamah-Muthu SS. Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am J Clin Nutr 2016;103:1111-24.
33. Goldfein KR, Slavin JL.Why sugar is added to food: Food science 101. Compr Rev Food Sci Food Saf 2015;14:644-56.
34. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: A systematic review and dose-response metaanalysis of cohort studies. Am J Clin Nutr 2013;98:1066-83.
35. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y, Li Q. Dairy products consumption and risk of type 2 diabetes: Systematic review and dose-response meta-analysis. PLoS One 2013;8:e73965.
36. Elwood PC, Pickering JE, Givens DI, Gallacher JE. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: An overview of the evidence. Lipids 2010;45: 925-39.
37. Tong X, Dong JY, Wu ZW, LiW, Qin LQ. Dairy consumption and risk of type 2 diabetesmellitus: Ameta-analysis of cohort studies. Eur J Clin Nutr 2011;65:1027-31.
38. Hruby A, Ma J, Rogers G, Meigs JB, Jacques PF. Associations of dairy intake with incident prediabetes or diabetes in middle-aged adults vary by both dairy type and glycemic status. J Nutr 2017;147: 1764-75.
39. Talaei M, Pan A, Yuan JM, Koh WP. Dairy intake and risk of type 2 diabetes. Clin Nutr 2018;37:712-8.
40. Brouwer-Brolsma EM, vanWoudenbergh GJ, Oude Elferink SJ, Singh-Povel CM, Hofman A, Dehghan A, Franco OH, Feskens EJ. Intake of different types of dairy and its prospective association with risk of type 2 diabetes: The Rotterdam Study. Nutr Metab Cardiovasc Dis 2016;26:987-95.
41. Virtanen HEK, Koskinen TT, Voutilainen S, Mursu J, Tuomainen TP, Kokko P, Virtanen JK. Intake of different dietary proteins and risk of type 2 diabetes in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 2017;117:882-93.
42. Soedamah-Muthu SS, de Goede J. Dairy consumption and cardiometabolic diseases: Systematic review and updated metaanalyses of prospective cohort studies. Curr Nutr Rep 2018;7:171-82.
43. Bergholdt HK, Nordestgaard BG, Ellervik C. Milk intake is not associatedwithlowriskof diabetes or overweight-obesity:aMendelian Randomization study in 97, 811 Danish individuals. Am J Clin Nutr 2015;102:487-96.
44. Gösta B. Dairy processing handbook. Lund (Sweden): Tetra Pak Processing Systems AB; 2003.
45. Diáz-López A, Bulló M, Martínez-González MA, Corella D, Estruch R, Fitó M, Gómez-Gracia E, Fiol M, Garciá de la Corte FJ, Ros E, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr 2016;55:349-60.
46. Guasch-Ferré M, Becerra-Tomás N, Ruiz-Canela M, Corella D, Schröder H, Estruch R, Ros E, Arós F, Gómez-Gracia E, Fiol M, et al. Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevención con Dieta Mediterránea (PREDIMED) study. Am J Clin Nutr 2017;105:723-35.
47. Pimpin L, Wu JH, Haskelberg H, DelGobbo L, Mozaffarian D. Is butter back A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, total mortality. PLoS One 2016;11:e0158118.
48. Buijsse B, Boeing H, Drogan D, SchulzeMB, Feskens EJ, Amiano P, Barricarte A, Clavel-Chapelon F, de Lauzon-Guillain B, Fagherazzi G, et al. Consumption of fatty foods and incident type 2 diabetes in populations from eight European countries. Eur J Clin Nutr 2015;69:455-61.
49. Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallström P, Gullberg B, Wirfält E, Orho-Melander M. Food sources of fatmay clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr 2015;101:1065-80.
50. Montonen J, Jarvinen R, Heliovaara M, Reunanen A, Aromaa A, Knekt P. Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr 2005;59:441-8.
51. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, obesity: A comprehensive review. Circulation 2016;133:187-225.
52. Brouwer-Brolsma EM, Sluik D, Singh-Povel CM, Feskens EJM. Dairy product consumption is associated with pre-diabetes and newly diagnosed type 2 diabetes in the Lifelines Cohort Study. Br J Nutr 2018;119:442-55.
53. Eussen SJ, van Dongen MC, Wijckmans N, den Biggelaar L, Oude Elferink SJ, Singh-Povel CM, Schram MT, Sep SJ, van der Kallen CJ, Koster A, et al. Consumption of dairy foods in relation to impaired glucosemetabolismand type 2 diabetesmellitus: TheMaastricht Study. Br J Nutr 2016;115:1453-61.
54. Turner KM, Keogh JB, Clifton PM. Dairy consumption and insulin sensitivity: A systematic review of short- A nd long-term intervention studies. Nutr Metab Cardiovasc Dis 2015;25:3-8.
55. Benatar JR, Sidhu K, Stewart RA. Effects of high and low fat dairy food on cardio-metabolic risk factors: A meta-analysis of randomized studies. PloS One 2013;8:e76480.
56. O'Connor S, Turcotte AF, Gagnon C, Rudkowska I. Increased dairy product intake modifies plasma glucose concentrations and glycated hemoglobin: A systematic review and meta-analysis of randomized controlled trials. Adv Nutr 2019;10:262-79.
57. Drouin-Chartier JP, Brassard D, Tessier-Grenier M, Côté JA, Labonté ME, Desroches S, Couture P, Lamarche B. Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Adv Nutr 2016;7: 1026-40.
58. American Diabetes Association. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl 1):S61-78.
59. Drouin-Chartier JP, Côté JA, Labonté ME, Brassard D, Tessier-Grenier M, Desroches S, Couture P, Lamarche B. Comprehensive review of the impact of dairy foods and dairy fat on cardiometabolic risk. Adv Nutr 2016;7:1041-51.
60. Engel S, Elhauge M, Tholstrup T. Effect of whole milk compared with skimmed milk on fasting blood lipids in healthy adults: A 3-week randomized crossover study. Eur J Clin Nutr 2018;72:249-54.
61. Raziani F, Tholstrup T, KristensenMD, SvanegaardML, Ritz C, Astrup A, Raben A.High intake of regular-fat cheese compared with reducedfat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: A randomized controlled trial. Am J Clin Nutr 2016;104:973-81.
62. Barengolts E, Smith ED, Reutrakul S, Tonucci L, Anothaisintawee T. The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: A meta-analysis of nine randomized controlled trials. Nutrients 2019;11:671.
63. van Meijl LE, Mensink RP. Effects of low-fat dairy consumption on markers of low-grade systemic inflammation and endothelial function in overweight and obese subjects: An intervention study. Br J Nutr 2010;104:1523-7.
64. Benatar JR, Jones E, White H, Stewart RA. A randomized trial evaluating the effects of change in dairy food consumption on cardiometabolic risk factors. Eur J Prev Cardiol 2014;21:1376-86.
65. Dugan CE, Barona J, Fernandez ML. Increased dairy consumption differentially improves metabolic syndrome markers in male and female adults. Metab Syndr Relat Disord 2014;12:62-9.
66. Turner KM, Keogh JB, Clifton PM. Red meat, dairy, insulin sensitivity: A randomized crossover intervention study.AmJ ClinNutr 2015;101:1173-9.
67. Wennersberg MH, Smedman A, Turpeinen AM, Retterstol K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, et al.Dairy products and metabolic effects in overweight men and women: Results from a 6-mo intervention study. Am J Clin Nutr 2009;90:960-8.
68. Stancliffe RA, Thorpe T, Zemel MB. Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr 2011;94:422-30.
69. Rideout TC, Marinangeli CP, Martin H, Browne RW, Rempel CB. Consumption of low-fat dairy foods for 6 months improves insulin resistance without adversely affecting lipids or bodyweight in healthy adults: A randomized free-living cross-over study. Nutr J 2013;12:56.
70. Katz D, Elmore J, Wild D, Lucan S. Jekels' epidemiology, biostatistics, preventive medicine, public health. 4th ed. Philadelphia (PA): Saunders; 2013.
71. Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr 2013;109:718-26.
72. Bowen J, Noakes M, Clifton PM. Effect of calcium and dairy foods in high protein, energy-restricted diets on weight loss and metabolic parameters in overweight adults. Int J Obes (Lond) 2005;29: 957-65.
73. Gardner CD, Messina M, Kiazand A, Morris JL, Franke AA. Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: A randomized trial. J Am Coll Nutr 2007;26:669-77.
74. Jones KW, Eller LK, Parnell JA, Doyle-Baker PK, Edwards AL, Reimer RA. Effect of a dairy- A nd calcium-rich diet on weight loss and appetite during energy restriction in overweight and obese adults: A randomized trial. Eur J Clin Nutr 2013;67:371-6.
75. St-Onge MP, Goree LLT, Gower B. High-milk supplementation with healthy diet counseling does not affect weight loss but ameliorates insulin action compared with low-milk supplementaion in overwight children. J Nutr 2009;139:933-8.
76. ThompsonWG, RostadHoldman N, JanzowDJ, Slezak JM, MorrisKL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res 2005;13:1344-53.
77. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012;28:539-43.
78. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94.
79. Mohamadshahi M, Veissi M, Haidari F, Javid AZ, Mohammadi F, Shirbeigi E. Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial. J Res Med Sci 2014;19:531-6.
80. Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebocontrolled study. Clin Nutr 2017;36:85-92.
81. Gilbert JA, Joanisse DR, Chaput JP, Miegueu P, Cianflone K, Almeras N, Tremblay A. Milk supplementation facilitates appetite control in obese women during weight loss: A randomised, single-blind, placebocontrolled trial. Br J Nutr 2011;105:133-43.
82. McGregor RA, Poppitt SD. Milk protein for improved metabolic health: A review of the evidence. Nutr Metab (Lond) 2013;10:46.
83. Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, Gansler T, Glynn T, Smith RA, Taubert K, et al. Preventing cancer, cardiovascular disease, diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, the American Heart Association. Circulation 2004;109:3244-55.
84. Morio B, Fardet A, Legrand P, Lecerf JM. Involvement of dietary saturated fats, from all sources or of dairy origin only, in insulin resistance and type 2 diabetes. Nutr Rev 2016;74:33-47.
85. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kroger J, SchulzeMB, Crowe FL, Huerta JM, Guevara M, Beulens JWJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2014;2:810-8.
86. Smedman AEM, Gustafsson IB, Berglund LGT, Vessby BOH. Pentadecanoic acid in serumas amarker for intake ofmilk fat: Relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999;69:22-9.
87. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:503-10.
88. Warensjo E, Jansson JH, Berglund L, Boman K, Ahren B, Weinehall L, Lindahl B, Hallmans G, Vessby B. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br J Nutr 2004;91:635-42.
89. Warensjo E, Jansson JH, Cederholm T, Boman K, Eliasson M, HallmansG, Johansson I, Sjogren P. Biomarkers ofmilk fat and the risk of myocardial infarction in men and women: A prospective, matched case-control study. Am J Clin Nutr 2010;92:194-202.
90. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, new-onset diabetes in U.S. adults: A cohort study. Ann Intern Med 2010;153:790-9.
91. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, incident diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013;97: 854-61.
92. Mansson HL. Fatty acids in bovine milk fat. Food Nutr Res 2008;52:1821.
93. KratzM, Marcovina S, Nelson JE, Yeh MM, Kowdley KV, Callahan HS, Song XL, Di CZ, Utzschneider KM. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, liver fat but not -cell function in humans. Am J Clin Nutr 2014;99:1385-96.
94. Zemel MB, Zhao F. (Role of whey protein and whey components in weight management and energy metabolism). Wei Sheng Yan Jiu 2009;38:114-7.
95. Comerford KB, Pasin G. Emerging evidence for the importance of dietary protein source on glucoregulatorymarkers and type 2 diabetes: Different effects of dairy, meat, fish, egg, plant protein foods. Nutrients 2016;8:446.
96. FernandezMA, Panahi S, Daniel N, Tremblay A, MaretteA.Yogurt and cardiometabolic diseases: A critical review of potential mechanisms. Adv Nutr 2017;8:812-29.
97. Veiga P, Pons N, Agrawal A, Oozeer R, Guyonnet D, Brazeilles R, Faurie JM, van Hylckama Vlieg JE, Houghton LA, Whorwell PJ, et al. Changes of the human gut microbiome induced by a fermented milk product. Sci Rep 2014;4:6328.
98. RobertsonMD, Bickerton AS, Dennis AL, VidalH, Frayn KN. Insulinsensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005;82: 559-67.
99. Layden BT, Yalamanchi SK, Wolever TM, Dunaif A, Lowe WL, Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes 2012;5:49-55.
100. Riós-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 2016;7:185.
101. Canfora EE, Blaak EE. Acetate: A diet-derived key metabolite in energy metabolism: Good or bad in context of obesity and glucose homeostasis Curr Opin Clin Nutr Metab Care 2017;20:477-83.
102. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015;11: 577-91.
103. Blanco-Rojo R, Alcala-Diaz JF, Wopereis S, Perez-Martinez P, Quintana-Navarro GM, Marin C, Ordovas JM, van Ommen B, Perez-Jimenez F, Delgado-Lista J, et al. The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: The CORDIOPREVDIAB randomised clinical trial. Diabetologia 2016;59:67-76.
104. Yubero-Serrano EM, Delgado-Lista J, Tierney AC, Perez-Martinez P, Garcia-Rios A, Alcala-Diaz JF, Castanõ JP, Tinahones FJ, Drevon CA, Defoort C, et al. Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: The LIPGENE study. Am J Clin Nutr 2015;102: 1509-17.
105. Trouwborst I, Bowser SM, Goossens GH, Blaak EE. Ectopic fat accumulation in distinct insulin resistant phenotypes; targets for personalized nutritional interventions. Front Nutr 2018;5:77.
106. Manja V, Lakshminrusimha S. Epidemiology and clinical research design, part 2: Principles. Neoreviews 2015;16:e94-e108.